Search PubMedSearch

PubMed · 2068238

A characteristic change in infant mortality rate decrease in Japan.

Abstract

Changes in infant mortality rate (IM) in Japan were observed over a 41-year period, since the end of the Second World War (1947-1987). Both neonatal mortality rate (NM) and infant mortality rate excluding neonatal deaths (IEN) were measured. It was observed that IM had considerably decreased during the observation period. A decrease of IEN contributed greatly to this fall till the 1960s and less so since the 1970s. The slope of the decrease of NM became steeper after entering the 1980s compared with that of IEN, and this contributed to the decrease of IM in this period. In order to analyse this phenomenon, detailed observations were made of the causes of death. On studying three of the major causes of infant deaths in Japan (congenital anomalies, birth trauma and perinatal asphyxia, and injuries and poisoning) it was found that there was only a small annual difference in the number of deaths due to congenital anomalies compared with the much greater difference seen with the other two causes; therefore, improvement of mortality rate by congenital anomalies seemed difficult because the efficacy of improvement of medical treatment and care are already approaching their limits. For a further reduction of IM in the future, improvement of perinatal care and prevention of injuries are considered to be essential.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Y Nakamura, M Nagai, H Yanagawa. 1991. A characteristic change in infant mortality rate decrease in Japan.. https://doi.org/10.1016/s0033-3506(05)80289-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Lowering increased cholesterol--prolonging life?].

Epidemiologic surveys reveal a positive correlation between serum cholesterol levels and the incidence of coronary artery disease. Intervention trials demonstrated that a reduction of serum cholesterol by 1% results in a decrease of coronary non-fatal events by 2%. Fatal coronary events remain almost uninfluenced. On the other side, several intervention trials showed an excess mortality from non-cardiac causes in the therapy groups (i.e. malignant tumors, suicides, accidents). Thus, until now no prolongation of life expectancy could be verified by cholesterol lowering measures.

Cause of Death